Metraipolis › archive › dc_d066ea005a9c

Cardiovascular safety pharmacology: beyond arrhythmic risk assessment — Europe PMC PMID:41445862

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41445862
DOI: 10.3389/fcvm.2025.1623644
License (as archived): solo-consultazione
Archived: 2026-10-08T15:45:55.788Z
SHA-256 of the archived text: f6c1ac951c86605da66e95f504c1787cb5c1ba93b0ed0f93c98a7cd952059018
Stable URL of this page: https://metraipolis.com/documento/dc_d066ea005a9c

How to cite

Cardiovascular safety pharmacology: beyond arrhythmic risk assessment — Europe PMC PMID:41445862 — Europe PMC (en), https://europepmc.org/article/MED/41445862 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d066ea005a9c (Metraipolis archive dc_d066ea005a9c, sha256 f6c1ac951c86605da66e95f504c1787cb5c1ba93b0ed0f93c98a7cd952059018)

BibTeX

@misc{dcd066ea005a9c,
  title = {Cardiovascular safety pharmacology: beyond arrhythmic risk assessment — Europe PMC PMID:41445862},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41445862},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d066ea005a9c; sha256 f6c1ac951c86605da66e95f504c1787cb5c1ba93b0ed0f93c98a7cd952059018},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41445862. Agents can read the archived copy with the MCP tool read_document.